The development of this group's activities abroad, particularly in emerging markets, is undoubtedly one of the most important elements to take into account when analysing this action.
Currently, as of 30 July 2020, the number of Astrazeneca Group shares outstanding on the market is 1,312 million. These shares are traded on several financial markets, as the company benefits from a triple listing. Astrazeneca shares are listed on the London Stock Exchange, the Stockholm Stock Exchange and the New York Stock Exchange under the symbol AZN.